Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine

Clinical trial NCT07740733 · COMPLETED

Trial details

NCT number: NCT07740733
Sponsor: Beijing Minhai Biotechnology Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Tetanus Vaccine

Start date: 2024-02-29
Primary completion: 2024-12-23
Enrollment: 1240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.